Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications association between tumor necrosis factor inhibitor tnfi therapy changes c reactive
… from its vendors may be stored, processed, transferred between and accessed from the United States or other … consent or under Standard Contractual Clauses in place between RTI-HS and the study sponsor. We reserve the right to … in the study informed consent form, where applicable. 6 CHANGES TO THIS POLICY RTI-HS complies with the legal, …
… ICR Section I Structure One of the key ICR differences between IPAY 2026 and 2027 is the existence of multiple … evidence to include Request to include place in therapy for the selected drug Suggested specific population … that patient experience information be differentiated between those currently taking the drug from those who have …
… the recommended genetic testing in this population. Publications: Bhandari NR, Hess LM, Parikh RC, Sireci AN, …
… for sharing documents and non-personal or anonymized data between RTI and your organization to support collaboration on … of project contracts or other legal agreements in place between RTI-HS and you or your organization. …
… Meeting on Women's Cancer. Real-world evaluation of PARP inhibitor tolerability in advanced ovarian cancer – …
Literature Reviews Evidence-based decision-making is critical in health care. Literature reviews help you understand the published evidence related to your research questions—whether the results will be used to inform your drug development and …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… On the other hand, companies are seeking greater alignment between the preparation of the EMA regulatory dossier and the … in advance, and nimbly adjust to the final scope and label changes. In addition, we provide a range of strategy, …
ISOQOL 2023 Share on: Wednesday, October 18 - Saturday, October 21, 2023 Conference website 30 Years of ISOQOL: Quality of Life – making it relevant. Research and presentations by RTI Health Solutions experts are on the program for ISOQOL 2023. An …
… Overall survival with palbociclib (PAL) plus an aromatase inhibitor (AI) versus AI alone in older patients (pts) with … analysis. Brufsky A, Sandin R, Stergiopoulos S, Chen C, Karanth SD , Li B, Esterberg L , Makari D, Candrilli S, …
… - into a single number or label. The American Statistical Association has issued a warning against statistical … both effect size and precision. To describe the connection between a confidence interval and a P-value function. …